|
1
|
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.
|
Nat Genet
|
2007
|
2.48
|
|
2
|
Biliary reconstruction using a side-to-side choledochocholedochostomy with or without T-tube in deceased donor liver transplantation: a prospective randomized trial.
|
Ann Surg
|
2009
|
2.19
|
|
3
|
Different cava reconstruction techniques in liver transplantation: piggyback versus cava resection.
|
Hepatobiliary Pancreat Dis Int
|
2014
|
2.08
|
|
4
|
Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation.
|
Transpl Int
|
2009
|
1.77
|
|
5
|
Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
|
Liver Transpl
|
2007
|
1.49
|
|
6
|
Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome.
|
Liver Transpl
|
2008
|
1.47
|
|
7
|
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
|
Transplantation
|
2004
|
1.33
|
|
8
|
A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.
|
J Hepatol
|
2007
|
1.27
|
|
9
|
Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
|
Ann Surg Oncol
|
2011
|
1.24
|
|
10
|
Chronic renal dysfunction following liver transplantation.
|
Clin Transplant
|
2008
|
1.04
|
|
11
|
The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers.
|
Cryobiology
|
2010
|
1.03
|
|
12
|
Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
|
Eur J Gastroenterol Hepatol
|
2007
|
0.97
|
|
13
|
Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver.
|
Surgery
|
2012
|
0.95
|
|
14
|
Chemokine receptor 5Delta32 mutation reduces the risk of acute rejection in liver transplantation.
|
Ann Transplant
|
2009
|
0.94
|
|
15
|
Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation.
|
Nephron Exp Nephrol
|
2009
|
0.94
|
|
16
|
Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin.
|
Transplantation
|
2006
|
0.91
|
|
17
|
Safety of liver resection and effect on quality of life in patients with benign hepatic disease: single center experience.
|
BMC Surg
|
2011
|
0.88
|
|
18
|
Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
|
Clin Transplant
|
2006
|
0.88
|
|
19
|
Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease.
|
Scand J Gastroenterol
|
2008
|
0.86
|
|
20
|
How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test.
|
Transpl Int
|
2010
|
0.85
|
|
21
|
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection.
|
J Hepatol
|
2006
|
0.85
|
|
22
|
Bovine pericardium for portal vein reconstruction in abdominal surgery: a surgical guide and first experiences in a single center.
|
Dig Surg
|
2015
|
0.85
|
|
23
|
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
|
Hepatology
|
2009
|
0.84
|
|
24
|
MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course.
|
Am J Transplant
|
2005
|
0.84
|
|
25
|
Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trial.
|
Transpl Int
|
2006
|
0.83
|
|
26
|
Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis.
|
Clin Transplant
|
2012
|
0.83
|
|
27
|
Improvement of microsurgical techniques in orthotopic rat liver transplantation.
|
J Surg Res
|
2008
|
0.82
|
|
28
|
In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation.
|
Am J Transplant
|
2005
|
0.82
|
|
29
|
Risk factors of metabolic disorders after liver transplantation: an analysis of data from fasted patients.
|
Transplantation
|
2015
|
0.82
|
|
30
|
Local cooling restores microcirculatory hemodynamics after closed soft-tissue trauma in rats.
|
J Trauma
|
2006
|
0.82
|
|
31
|
Lidocaine/monoethylglycinexylidide test, galactose elimination test, and sorbitol elimination test for metabolic assessment of liver cell bioreactors.
|
Artif Organs
|
2010
|
0.82
|
|
32
|
Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
|
Exp Clin Transplant
|
2009
|
0.82
|
|
33
|
CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?
|
Eur Radiol
|
2015
|
0.82
|
|
34
|
Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
|
Ann Transplant
|
2007
|
0.80
|
|
35
|
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
|
J Hepatol
|
2008
|
0.80
|
|
36
|
Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies.
|
Genet Test Mol Biomarkers
|
2009
|
0.80
|
|
37
|
Improved microcirculation by low-viscosity histidine- tryptophan-ketoglutarate graft flush and subsequent cold storage in University of Wisconsin solution: results of an orthotopic rat liver transplantation model.
|
Transpl Int
|
2008
|
0.80
|
|
38
|
Incidence, risk factors and management of incisional hernia in a high volume liver transplant center.
|
Ann Transplant
|
2013
|
0.79
|
|
39
|
Predictors of quality of life in patients evaluated for liver transplantation.
|
Clin Transplant
|
2014
|
0.79
|
|
40
|
Recovery of preservation-injured primary human hepatocytes and nonparenchymal cells to tissuelike structures in large-scale bioreactors for liver support: an initial transmission electron microscopy study.
|
J Invest Surg
|
2003
|
0.79
|
|
41
|
No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease.
|
Alcohol Clin Exp Res
|
2008
|
0.79
|
|
42
|
Endoscopic management of biliary obstruction after successful reuse of a liver graft.
|
Ann Transplant
|
2009
|
0.79
|
|
43
|
Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
|
Liver Transpl
|
2006
|
0.78
|
|
44
|
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
|
HPB (Oxford)
|
2014
|
0.78
|
|
45
|
Impact of organ preservation using HTK for graft flush and subsequent storage in UW in rat kidney transplantation.
|
Eur Surg Res
|
2006
|
0.78
|
|
46
|
Primary permanent arterialization of the portal vein in liver transplantation.
|
Transpl Int
|
2003
|
0.78
|
|
47
|
Initial liver graft function is a reliable predictor of tacrolimus trough levels during the first post-transplant week.
|
Clin Transplant
|
2010
|
0.77
|
|
48
|
Chemokine Receptor-5Delta32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation.
|
J Transplant
|
2009
|
0.77
|
|
49
|
Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy.
|
Pancreas
|
2015
|
0.76
|
|
50
|
Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysis.
|
Transpl Int
|
2011
|
0.76
|
|
51
|
Growth hormone/insulin-like growth factor 1 dynamics in adult living donor liver transplantation.
|
Liver Transpl
|
2014
|
0.75
|
|
52
|
Warm HTK donor pretreatment reduces liver injury during static cold storage in experimental rat liver transplantation.
|
Hepatobiliary Pancreat Dis Int
|
2015
|
0.75
|
|
53
|
Iloprost donor treatment reduces ischemia-reperfusion injury in an isolated extracorporeal pig liver perfusion model.
|
Exp Clin Transplant
|
2015
|
0.75
|
|
54
|
Porcine liver decellularization under oscillating pressure conditions: a technical refinement to improve the homogeneity of the decellularization process.
|
Tissue Eng Part C Methods
|
2014
|
0.75
|
|
55
|
Acute cardiorenal syndrome by high flow arteriovenous fistula after kidney transplantation.
|
J Vasc Access
|
2013
|
0.75
|
|
56
|
Endovascular treatment of supra-celiac aortic pseudoaneurysms following liver transplantation.
|
Clin Transplant
|
2009
|
0.75
|
|
57
|
Cardiovascular risk and events after liver transplantation. Experiences from 313 consecutive transplants with a follow-up of 20 years.
|
Clin Transplant
|
2015
|
0.75
|
|
58
|
Endovascular treatment of supratruncal aortic hemorrhage following liver transplantation as a bridging procedure for hepatic retransplantation.
|
Liver Transpl
|
2009
|
0.75
|
|
59
|
YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
|
J Gastroenterol Hepatol
|
2013
|
0.75
|
|
60
|
Survival without biliary complications after liver transplant for primary sclerosing cholangitis.
|
Exp Clin Transplant
|
2013
|
0.75
|
|
61
|
Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.
|
J Gastrointest Surg
|
2014
|
0.75
|